Page 11 - Q3 Results

Bata India Q3 net profit up 12.6% at ₹66.1 cr, revenue rises 2.8%

Leading shoemaker Bata India Ltd on Monday reported a 12.61 per cent rise in consolidated net profit to Rs 66.1 crore in the December quarter of FY'26 compared to the year-ago period. It had posted a net profit of Rs 58.7 crore in the previous October-December a year ago, according to a regulatory filing from Bata India. Bata's revenue from operations was up 2.81 per cent to Rs 944.68 crore during the quarter under review compared to Rs 918.79 crore in the corresponding quarter a year ago. Its total expenses in the December quarter were at Rs 868.92 crore, up 3.3 per cent on a year-on-year basis. Bata India's total income, which includes other income, was up 3.93 per cent to Rs 965.72 crore. Shares of Bata India Ltd on Monday settled at Rs 884.35 apiece on BSE, up 4.27 per cent.

SBI shares hit record high after Q3; brokerages raise target up to ₹1,300

SBI shares hit a fresh all-time high after Q3FY26 results beat estimates. Brokerages raise earnings forecasts and target prices to ₹1,300, maintaining buy calls

Aurobindo Pharma Q3FY26 results: Net profit rises 8% to ₹910 crore

Aurobindo Pharma on Monday said its consolidated net profit increased 8 per cent year-on-year to Rs 910 crore for the December quarter, led by robust sales in Europe and the US. The Hyderabad-based drug major reported a net profit of Rs 846 crore for the October-December period of the last fiscal year. Total revenue from operations increased to Rs 8,646 crore during the quarter as compared with Rs 7,979 crore in the year-ago period, the drug firm said in a statement. "Q3 reflected steady execution across Aurobindo's core businesses, supported by stable demand and the strength of our diversified product portfolio in key markets, including the US and Europe," Aurobindo Pharma Vice-Chairman and MD K Nithyananda Reddy said. Growth remained measured, with continued focus on operational discipline and a balanced approach to growth and profitability, he added. "As we progress our strategic initiatives, we remain cautious yet confident in our ability to support sustainable value creation

Zydus Lifesciences Q3 net profit rises 9% on strong US and India growth

Zydus Lifesciences posted higher Q3 profit and revenue, aided by strong growth in the US and India businesses, improved margins, and steady momentum in generics, specialty and chronic segments

Sky Gold and Diamonds posts over twofold jump in Q3 profit at ₹81 cr

Sky Gold and Diamonds Ltd on Monday reported more than twofold jump in consolidated profit to Rs 80.53 crore for the December quarter. Its net profit stood at Rs 36.53 crore in the year-ago period. Total income rose to Rs 1,775.12 crore during the October-December period of the fiscal year from Rs 1,005.09 crore in the corresponding period of the preceding year, according to a regulatory filing. Established in 2008, Mumbai-based Sky Gold and Diamonds Ltd is a B2B jewellery manufacturers, specialising in lightweight, design-led and studded jewellery. The company serves India's leading jewellery retailers and is expanding into global markets.

Public sector banks post 18% growth to record ₹52,603 cr profit in Q3 FY26

Led by the country's biggest lender State Bank of India (SBI), public sector banks logged a record cumulative profit of Rs 52,603 crore in the third quarter of the current fiscal, reflecting an 18 per cent year-on-year growth. All 12 public sector banks (PSBs) together made a profit of Rs 44,473 crore in the December quarter of FY25. Thus, the increase in profit in absolute terms was Rs 8,130 crore as compared to the same quarter of the previous financial year. Market leader SBI alone contributed 40 per cent to the total earnings of Rs 52,603 crore, as per the published numbers on stock exchanges. SBI posted the highest quarterly net profit of Rs 21,028 crore in Q3 FY26, 24 per cent higher than the same period of the previous fiscal. In percentage terms, Chennai-based Indian Overseas Bank reported the highest net profit growth of 56 per cent to Rs 1,365 crore, followed by Central Bank of India with a 32 per cent rise to Rs 1,263 crore. During the quarter, all 12 public sector bank

GlaxoSmithKline Pharma Q3 profit up 29 pc at Rs 296 cr

GlaxoSmithKline Pharmaceuticals on Monday posted 29 per cent increase in consolidated profit after tax at Rs 296 crore for the third quarter ended December 31, 2025. The drugmaker reported a profit after tax of Rs 230 crore for the October-December period of last fiscal. Revenue from operations rose to Rs 1,041 crore from Rs 949 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals Ltd said in a regulatory filing. The company said its competitive performance comes against the backdrop of the broader macro environment and efforts to mitigate internal supply challenges. The implementation of the new Labour Codes did not have a material impact on the company, it added. Shares of the company on Monday settled 1.01 per cent up at Rs 2,511 apiece on BSE.

Sterlite Technologies zooms 66% in 10 days, stock hits 18-month high

STL is at the intersection of 3 powerful multiyear investment cycles, FTTx, data centers and 5G, creating a strong structural tailwind of optical infrastructure.

SCI jumps 19% to 2-mth high as Q3 net profit surges; buy or book profit?

The scrip increased as much as 18.9 per cent to the day's high of ₹264, the highest level since November 18, 2025

Zydus Life Q3 result: Profit up marginally at ₹1,042 cr, revenue jumps 32%

Zydus Life Q3 Ebitda for the quarter was ₹1,816.4 crore, up 31 per cent Y-o-Y. Ebitda margin during the same period stood at 26.5 per cent, marking an improvement of 20 basis points

Tata, JSW, Jindal Steel at new high; rally up to 18% in 1 month; here's why

India's steel consumption to grow by 8 per cent- 9 per cent in the next few years, aided by strong demand from the infrastructure, construction and manufacturing sectors, believe analysts.

Hindustan Zinc, JNCASR develop zinc-ion battery prototype; stock rises 3%

Shares of Hindustan Zinc rose on Monday as the company developed, in collaboration with the JNCASR, stable and reliable zinc-ion battery pouch cell prototypes for large-scale renewable energy storage

Kalyan Jewellers share price jumps 12% after Q3 net profit surges 90% YoY

The scrip jumped 11.7 per cent to the day's high of ₹424.70 on the National Stock Exchange (NSE)

Gems & Jewellery stocks: Goldiam, Kalyan, Senco, Thangamayil zoom up to 18%

If tariff rates on gems and jewellery are reduced to zero, it will bring major relief to India's gems and jewellery sector, which counts the US as its largest export market, said ICICI Securities.

JK Tyre and Industries jumps 7%, hits all-time high on posting strong Q3

The buying on the counter came after the company released its Q3FY26 numbers on Friday, after market hours. Brokerages believe the company posted modest numbers

Nifty PSU Bank index rallies nearly 4%, hits new high; what's driving PSBs?

In the past one month, the Nifty PSU Bank index has outperformed the market by surging 7 per cent, as against 0.5 per cent gain in the Nifty 50.

Tata Steel shares hit all-time high post Q3; brokerages raise target price

The buying on the counter came after most brokerages raised their target on Tata Steel post its December quarter (Q3FY26) results released on February 6, 2026, after market hours

Britannia Q3 preview: Profit may rise 18%; margins, volumes to improve

Britannia Q3 results preview: Brokerages tracked by Business Standard estimate Britannia's net profit to average ₹687 crore, compared to ₹581.7 crore a year ago, up 18 per cent year-on-year (Y-o-Y)

Q3 results: Pfizer, Zydus Lifesciences, Aurobindo Pharma, 181 more on Feb 9

Q3FY26 company results: Firms including GlaxoSmithKline Pharmaceuticals, The Ramco Cements, Linde India, Gulf Oil Lubricants, and Bata India are also to release their October-December earnings today

Inflation data, Q3 earnings likely to drive stock markets this week

Inflation data, trading activity of foreign investors and global trends would dictate sentiment in the stock market this week, according to analysts. Besides, geopolitical developments and Q3 earnings will also guide market movement during the week. "This week features several important domestic and global triggers. In India, investors will closely track retail inflation data due on February 12 and foreign exchange reserves data on February 13, for insights into price trends and external sector stability. "The earnings calendar stays active, with key results expected from Titan Company and Mahindra & Mahindra, which may drive stock-specific action. Globally, participants will monitor a heavy US data calendar and performance of the Nasdaq Composite following its recent decline," Ajit Mishra, SVP, Research, Religare Broking Ltd, said. Geopolitical developments and their impact on commodity markets will also be closely watched, Mishra added. From the Q3 earnings space, Ashok Leyland,